Y Okada Selected Research

Y Okada Research Topics

Disease

36	Neoplasms (Cancer) 02/2012 - 01/2000
15	Carcinoma (Carcinomatosis) 04/2016 - 01/2000
10	Inflammation (Inflammations) 11/2016 - 10/2000
10	Neoplasm Metastasis (Metastasis) 11/2011 - 01/2000
9	Hemorrhage 08/2019 - 04/2000
8	Infections 11/2018 - 02/2000
7	Glioma (Gliomas) 08/2001 - 01/2000
6	Ischemia 01/2018 - 11/2000
6	Brain Death (Brain Dead) 04/2015 - 11/2000
6	Rheumatoid Arthritis 11/2014 - 05/2000
6	Wounds and Injuries (Trauma) 10/2014 - 11/2000
5	Carcinogenesis 01/2017 - 03/2000
5	Pathologic Constriction (Stenosis) 01/2016 - 04/2001
5	Thrombosis (Thrombus) 01/2016 - 04/2000
5	Glioblastoma (Glioblastoma Multiforme) 03/2001 - 01/2000
4	Leukemia 12/2018 - 09/2013
4	Hypoxia (Hypoxemia) 01/2018 - 11/2000
4	Bronchiolitis Obliterans 09/2017 - 11/2000
4	Melanoma (Melanoma, Malignant) 11/2011 - 10/2000
4	Hematoma 07/2011 - 12/2000
4	Ischemic Stroke 02/2010 - 10/2005
4	Osteoarthritis 06/2009 - 06/2000
4	Adenocarcinoma 06/2005 - 01/2000
4	Heart Arrest (Cardiac Arrest) 10/2001 - 11/2000
4	Burns 09/2001 - 01/2001
3	Familial Primary Pulmonary Hypertension 04/2018 - 11/2000
3	Body Weight (Weight, Body) 01/2018 - 02/2000
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 03/2000
3	Colitis 12/2013 - 10/2000
3	Insulin Resistance 05/2013 - 02/2000
3	Stroke (Strokes) 08/2010 - 10/2005
3	Necrosis 01/2007 - 04/2003
3	Lymphatic Metastasis 01/2007 - 01/2000
3	Adenoma (Adenomas) 04/2004 - 06/2001
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2001 - 11/2000
3	Testicular Neoplasms (Testicular Cancer) 05/2001 - 02/2000
3	Cataract (Cataracts) 12/2000 - 03/2000
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2000 - 02/2000
2	Primary Myelofibrosis (Myelosclerosis) 12/2018 - 12/2017
2	Lupus Nephritis 02/2018 - 02/2013
2	Reperfusion Injury 01/2018 - 10/2001
2	Hypertension (High Blood Pressure) 05/2013 - 02/2000
2	Cerebral Hemorrhage 08/2012 - 10/2005
2	Lung Neoplasms (Lung Cancer) 07/2012 - 12/2009
2	Pulmonary Edema 07/2012 - 01/2001
2	Lymphoma (Lymphomas) 02/2012 - 10/2001

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2000
12	Matrix Metalloproteinases (MMPs)IBA 02/2012 - 01/2000
11	CytokinesIBA 01/2018 - 10/2000
10	Messenger RNA (mRNA)IBA 10/2014 - 03/2000
8	Pharmaceutical PreparationsIBA 08/2019 - 04/2000
7	EnzymesIBA 02/2012 - 01/2000
7	Metalloproteases (Metalloproteinases)IBA 01/2007 - 01/2000
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2001
5	InterleukinsIBA 06/2006 - 10/2000
5	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2001 - 01/2000
4	Capsules (Microcapsules)IBA 10/2011 - 04/2000
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2009 - 03/2000
4	Hormones (Hormone)IBA 11/2004 - 02/2000
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2001 - 07/2000
4	Enzyme Precursors (Zymogens)IBA 11/2001 - 01/2000
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2001 - 06/2000
4	Tissue Inhibitor of Metalloproteinase-1IBA 03/2001 - 01/2000
4	Tissue Inhibitor of Metalloproteinase-2IBA 03/2001 - 01/2000
4	progelatinaseIBA 03/2001 - 01/2000
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2001
3	LipidsIBA 01/2017 - 04/2000
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 03/2001
3	Fibrinolysin FDA Link 01/2015 - 10/2000
3	Biomarkers (Surrogate Marker)IBA 02/2010 - 09/2005
3	Insulin (Novolin)FDA Link 05/2008 - 02/2000
3	Peptide Hydrolases (Proteases)FDA Link 01/2007 - 09/2000
3	Interleukin-1alpha (Interleukin 1 alpha)IBA 06/2006 - 04/2001
3	Indicators and Reagents (Reagents)IBA 06/2006 - 01/2001
3	Cisplatin (Platino)FDA LinkGeneric 01/2006 - 12/2000
3	AntigensIBA 10/2003 - 05/2000
3	Complementary DNA (cDNA)IBA 04/2003 - 02/2000
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2001 - 06/2000
3	AntibodiesIBA 08/2001 - 03/2000
3	Transforming Growth Factor beta (TGF-beta)IBA 03/2001 - 03/2000
3	Glucose (Dextrose)FDA LinkGeneric 11/2000 - 02/2000
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2018 - 02/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 03/2001
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 01/2001
2	PerforinIBA 09/2017 - 04/2006
2	P-SelectinIBA 01/2016 - 10/2010
2	Dextrans (Dextran)FDA Link 12/2013 - 05/2006
2	SodiumIBA 12/2013 - 05/2006
2	Therapeutic UsesIBA 06/2013 - 12/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2013 - 02/2010
2	AlkaliesIBA 02/2013 - 08/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2012 - 05/2001

Therapy/Procedure

12	Therapeutics 02/2018 - 01/2000
9	Lung Transplantation 11/2018 - 11/2002
6	Drug Therapy (Chemotherapy) 06/2010 - 02/2000
4	Resuscitation 10/2001 - 05/2000
3	Liver Transplantation 11/2016 - 11/2000
3	Sternotomy 01/2001 - 11/2000
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2016 - 01/2001
2	Renal Dialysis (Hemodialysis) 07/2012 - 12/2000